Portal venous donor-specific transfusion in conjunction with sirolimus prolongs renal allograft survival in nonhuman primates

American Journal of Transplantation

Volumn 9, Issue 1, 2009, Pages 124-131

  Dhanireddy, K K ^a,b   Bruno, D A ^a,b   Weaver, T A ^a,c   Xu, H ^a   Zhang, X ^a   Leopardi, F V ^a,c   Hale, D A ^a   Kirk, A D ^a,c  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Donor specific transfusion; Rhesus monkey; Tolerance

Indexed keywords

ALLOANTIBODY; RAPAMYCIN; TACROLIMUS;

ADJUVANT THERAPY; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CONTROLLED STUDY; DRUG EFFICACY; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; MONOTHERAPY; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; CHIMERA; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; KIDNEY TRANSPLANTATION; MACACA MULATTA; SIROLIMUS;

EID: 58049196889     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02448.x     Document Type: Article

References (40)

1. Lechler RI, Garden OA, Turka LA. The complementary roles of the deletion and regulation in transplantation tolerance. Nat Rev Immunol 2003 3 : 147 158.
2. Wood KJ, Bushell AR, Darby CR, Pearson TC, West L, Morris PJ. Mechanism of induction of transplantation tolerance using donor antigen and anti-CD4 monoclonal antibody. Transplant Proc 1991 23 : 133 134.
3. Hall BM, Fava L, Chen J et al. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4. J Immunol 1998 161 : 5147 5156.
4. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992 339 : 1579 1582.
5. Opelz G, Terasaki PI. Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 1978 299 : 799 803.
6. Sanfilippo F, Thacker L, Vaughn WK. Living-donor renal transplantation in SEOPF. The impact of histocompatibility, transfusions and cyclosporine on outcome. Transplantation 1990 49 : 25 29.
7. Sanfilippo F, Vaughn WK, Bollinger RR, Spees EK. The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival. Transplantation 1984 37 : 350 356.
8. Fontes P, Rao AS, Demetris AJ et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart and pancreas islet transplantation. Lancet 1994 344 : 151 155.
9. Zeevi A, Pavlick M, Banas R et al. Three years of follow-up of bone marrow-augmented organ transplant recipients: The impact on donor-specific immune modulation. Transplant Proc 1997 29 : 1205 1206.
10. Ciancio G, Miller J, Garcia-Morales RO et al. Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation 2001 71 : 827 835.
11. Mineo D, Ricordi C, Xu X et al. Combined islet and hematopoietic stem cell allotransplantation: A clinical pilot trial to induce chimerism and graft tolerance. Am J Transplant 2008 8 : 1262 1274.
12. Jordan SC, Pescovitz MD. Presensitization: The problem and its management. Clin J Am Soc Nephrol 2006 1 : 421 432.
13. Delis S, Ciancio G, Burke GW 3rd., Garcia-Morales R, Miller J. Donor bone marrow transplantation: Chimerism and tolerance. Transpl Immunol 2004 13 : 105 115.
14. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003 3 : 199 210.
15. Li Y, Li XC, Zheng XX, Wells AD, Turka LA, Strom TB. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999 5 : 1298 1302.
16. The Canadian Multicentre Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 1983 309 : 809 815.
17. Gardner B, Harris KR, Tate DG et al. The effect of pretransplant blood transfusions on renal allograft survival in patients on cyclosporine. Transplant Proc 1984 16 : 1172 1173.
18. Cats S, Terasaki P, Perdue S, Mickey MR. Effect of HLA typing and transfusions on cyclosporine-treated renal allograft recipients. N Engl J Med 1984 311 : 675 676.
19. Chase MW. Experimental sensitization with particular reference to picryl chloride. Int Arch Allergy Appl Immunol 1954 5 : 163 191.
20. Tokita D, Shishida M, Ohdan H et al. Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity. J Immunol 2006 177 : 3615 3624.
21. Onoe T, Ohdan H, Tokita D et al. Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice. J Immunol 2005 175 : 139 146.
22. Tokita D, Ohdan H, Onoe T, Hara H, Tanaka Y, Asahara T. Liver sinusoidal endothelial cells contribute to alloreactive T-cell tolerance induced by portal venous injection of donor splenocytes. Transpl Int 2005 18 : 237 245.
23. Schildberg FA, Hegenbarth SI, Schumak B, Limmer A, Knolle PA. Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. Eur J Immunol 2008 38 : 957 967.
24. Knolle PA, Schmitt E, Jin S et al. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 1999 116 : 1428 1440.
25. Diaz-Peromingo JA, Gonzalez-Quintela A. Influence of gadolinium-induced kupffer cell blockade on portal venous tolerance in rat skin allograft transplantation. Eur Surg Res 2005 37 : 45 49.
26. Morita H, Sugiura K, Inaba M et al. A strategy for organ allografts without using immunosuppressants or irradiation. Proc Natl Acad Sci U S A 1998 95 : 6947 6952.
27. Wang FS, Yamaguchi Y, Furuhashi T et al. Recipient blood pre-transplant transfusion prolongs hepatic allograft survival in rats. J Surg Res 2006 135 : 52 60.
28. Sato Y, Ichida T, Watanabe H et al. Repeating intraportal donor-specific transfusion may induce tolerance following adult living-related donor liver transplantation. Hepatogastroenterology 2003 50 : 601 606.
29. Trivedi HL, Shah VR, Vanikar AV et al. High-dose peripheral blood stem cell infusion: A strategy to induce donor-specific hyporesponsiveness to allografts in pediatric renal transplant recipients. Pediatr Transplant 2002 6 : 63 68.
30. Trivedi HL, Vanikar AV, Modi PR et al. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients. Transplant Proc 2005 37 : 737 742.
31. Preston EH, Xu H, Dhanireddy KK et al. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. Am J Transplant 2005 5 : 1032 1041.
32. Xu H, Montgomery SP, Preston EH et al. Studies investigating pre-transplant donor specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a non-human primate model of skin allotransplantation. J Immunol 2003 170 : 2776 2782.
33. Kirk AD, Harlan DM, Armstrong NN et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997 94 : 8789 8794.
34. Knechtle SJ, Vargo D, Fechner J et al. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation 1997 63 : 1 6.
35. Kirk AD, Burkly LC, Batty DS et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999 5 : 686 693.
36. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996 381 : 434 438.
37. Markees TG, Phillips NE, Noelle RJ et al. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 1997 64 : 329 335.
38. Rossini AA, Mordes JP, Markees TG, Phillips NE, Gordon EJ, Greiner DL. Induction of islet transplantation tolerance using donor specific transfusion and anti-CD154 monoclonal antibody. Transplant Proc 1999 31 : 629 632.
39. Azimzadeh AM, Pfeiffer S, Wu G et al. Alloimmunity in primate heart recipients with CD154 blockade: Evidence for alternative costimulation mechanisms. Transplantation. 2006 81 : 255 264.
40. Ringers J, Haanstra KG, Kroczek RA et al. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates. Transplantation 2002 73 : 862 866.